{"id":31,"date":"2014-07-18T13:17:21","date_gmt":"2014-07-18T13:17:21","guid":{"rendered":"http:\/\/delveinsightblog.wordpress.com\/?p=31"},"modified":"2021-08-23T12:05:31","modified_gmt":"2021-08-23T06:35:31","slug":"compare-the-global-sales-of-blockbuster-drugs-losing-patent-this-year-2014","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/compare-the-global-sales-of-blockbuster-drugs-losing-patent-this-year-2014","title":{"rendered":"Compare the Global Sales of Blockbuster Drugs Losing Patent in 2014"},"content":{"rendered":"\n

Compare the global sales of 2013 and 2012 of the top ten blockbuster drugs which is losing patent this year. Teva Pharmaceutical’s Copaxone is the most affected drugs in terms of sales as the sales of 2013 has increased to 4.328 billions bearing the highest loss. Least affected Drug is AbbVie’s Trilipix which has faced the decrease in sales from\u00a01.098 billions to 303 millions.<\/p>\n\n\n\n

\"\"
Blockbuster Drugs Global Sales 2012-13<\/figcaption><\/figure>\n\n\n\n

Table: Global Sales of Blockbuster Drugs for 2012 and 2013<\/p>\n\n\n\n

Brand Name<\/strong><\/td>Global Sales 2012 USD (b)<\/strong><\/td>Global Sales 2013<\/strong>\n

 <\/p>\n

USD (b)<\/strong><\/p>\n<\/td><\/tr>

Copaxone<\/strong><\/td>3.996<\/td>4.328<\/td><\/tr>
Nexium<\/strong><\/td>3.994<\/td>3.872<\/td><\/tr>
Micardis\/Micardis HCT<\/strong><\/td>2.217<\/td>0.97<\/td><\/tr>
Sandostatin LAR<\/strong><\/td>1.512<\/td>1.589<\/td><\/tr>
Exforge\/Exforge HCT<\/strong><\/td>1.352<\/td>1.456<\/td><\/tr>
Nasonex<\/strong><\/td>1.268<\/td>1.335<\/td><\/tr>
Trilipix<\/strong><\/td>1.098<\/td>0.303<\/td><\/tr>
Evista<\/strong><\/td>1.01<\/td>1.05<\/td><\/tr>
Renagel\/Renvela<\/strong><\/td>0.861<\/td>0.75<\/td><\/tr>
Restasis<\/strong><\/td>0.792<\/td>0.94<\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"

Compare the global sales of 2013 and 2012 of the top ten blockbuster drugs which is losing patent this year. Teva Pharmaceutical’s Copaxone is the most affected drugs in terms of sales as the sales of 2013 has increased to 4.328 billions bearing the highest loss. Least affected Drug is AbbVie’s Trilipix which has faced […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[122,123,186,239,240,275,276,277,401,415,421,506,516,531,563,584],"industry":[17225],"therapeutic_areas":[],"class_list":["post-31","post","type-post","status-publish","format-standard","hentry","category-articles","tag-blockbuster-drugs","tag-blockbuster-drugs-global-sales","tag-copaxone","tag-evista","tag-exforgeexforge-hct","tag-global-sales","tag-global-sales-2012","tag-global-sales-2013","tag-micardismicardis-hct","tag-nasonex","tag-nexium","tag-renagelrenvela","tag-restasis","tag-sandostatin-lar","tag-teva-pharmaceutical","tag-trilipix","industry-pharmaceutical"],"acf":[],"yoast_head":"\nGlobal Sales of Blockbuster Drugs Going Off Pattent In 2014<\/title>\n<meta name=\"description\" content=\"Compare the global sales of 2013 and 2012 of the top ten blockbuster drugs which is losing patent this year. Teva Pharmaceutical\u2019s Copaxone...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/compare-the-global-sales-of-blockbuster-drugs-losing-patent-this-year-2014\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Sales of Blockbuster Drugs Going Off Pattent In 2014\" \/>\n<meta property=\"og:description\" content=\"Compare the global sales of 2013 and 2012 of the top ten blockbuster drugs which is losing patent this year. Teva Pharmaceutical\u2019s Copaxone...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/compare-the-global-sales-of-blockbuster-drugs-losing-patent-this-year-2014\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-07-18T13:17:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-23T06:35:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2021\/08\/blockbuster-drugs-global-sales.png\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Global Sales of Blockbuster Drugs Going Off Pattent In 2014","description":"Compare the global sales of 2013 and 2012 of the top ten blockbuster drugs which is losing patent this year. Teva Pharmaceutical\u2019s Copaxone...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/compare-the-global-sales-of-blockbuster-drugs-losing-patent-this-year-2014","og_locale":"en_US","og_type":"article","og_title":"Global Sales of Blockbuster Drugs Going Off Pattent In 2014","og_description":"Compare the global sales of 2013 and 2012 of the top ten blockbuster drugs which is losing patent this year. Teva Pharmaceutical\u2019s Copaxone...","og_url":"https:\/\/www.delveinsight.com\/blog\/compare-the-global-sales-of-blockbuster-drugs-losing-patent-this-year-2014","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2014-07-18T13:17:21+00:00","article_modified_time":"2021-08-23T06:35:31+00:00","og_image":[{"url":"https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2021\/08\/blockbuster-drugs-global-sales.png","type":"","width":"","height":""}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/compare-the-global-sales-of-blockbuster-drugs-losing-patent-this-year-2014","url":"https:\/\/www.delveinsight.com\/blog\/compare-the-global-sales-of-blockbuster-drugs-losing-patent-this-year-2014","name":"Global Sales of Blockbuster Drugs Going Off Pattent In 2014","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/compare-the-global-sales-of-blockbuster-drugs-losing-patent-this-year-2014#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/compare-the-global-sales-of-blockbuster-drugs-losing-patent-this-year-2014#primaryimage"},"thumbnailUrl":"https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2021\/08\/blockbuster-drugs-global-sales.png","datePublished":"2014-07-18T13:17:21+00:00","dateModified":"2021-08-23T06:35:31+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Compare the global sales of 2013 and 2012 of the top ten blockbuster drugs which is losing patent this year. Teva Pharmaceutical\u2019s Copaxone...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/compare-the-global-sales-of-blockbuster-drugs-losing-patent-this-year-2014"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/compare-the-global-sales-of-blockbuster-drugs-losing-patent-this-year-2014#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2021\/08\/23120523\/blockbuster-drugs-global-sales.png","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2021\/08\/23120523\/blockbuster-drugs-global-sales.png","width":583,"height":345},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":null,"coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Blockbuster drugs<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Blockbuster Drugs Global Sales<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Copaxone<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Evista<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Exforge\/Exforge HCT<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">global sales<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Global Sales 2012<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Global Sales 2013<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Micardis\/Micardis HCT<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Nasonex<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Nexium<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Renagel\/Renvela<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Restasis<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Sandostatin LAR<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Teva Pharmaceutical<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Trilipix<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Blockbuster drugs<\/span>","<span class=\"advgb-post-tax-term\">Blockbuster Drugs Global Sales<\/span>","<span class=\"advgb-post-tax-term\">Copaxone<\/span>","<span class=\"advgb-post-tax-term\">Evista<\/span>","<span class=\"advgb-post-tax-term\">Exforge\/Exforge HCT<\/span>","<span class=\"advgb-post-tax-term\">global sales<\/span>","<span class=\"advgb-post-tax-term\">Global Sales 2012<\/span>","<span class=\"advgb-post-tax-term\">Global Sales 2013<\/span>","<span class=\"advgb-post-tax-term\">Micardis\/Micardis HCT<\/span>","<span class=\"advgb-post-tax-term\">Nasonex<\/span>","<span class=\"advgb-post-tax-term\">Nexium<\/span>","<span class=\"advgb-post-tax-term\">Renagel\/Renvela<\/span>","<span class=\"advgb-post-tax-term\">Restasis<\/span>","<span class=\"advgb-post-tax-term\">Sandostatin LAR<\/span>","<span class=\"advgb-post-tax-term\">Teva Pharmaceutical<\/span>","<span class=\"advgb-post-tax-term\">Trilipix<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 12 years ago","modified":"Updated 5 years ago"},"absolute_dates":{"created":"Posted on Jul 18, 2014","modified":"Updated on Aug 23, 2021"},"absolute_dates_time":{"created":"Posted on Jul 18, 2014 1:17 pm","modified":"Updated on Aug 23, 2021 12:05 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/31","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=31"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/31\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=31"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=31"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=31"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=31"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=31"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}